Showing results (81-90 of 124) with videos related to
Sort By:
Pageof 13
Cancer|July 23, 2013
Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan studyFrancesco Leone, Salvatore Artale, Donatella Marino, et al.Clinical Colorectal Cancer|April 2, 2018
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program StudyAlessandro Pastorino, Maria Di Bartolomeo, Evaristo Maiello, et al.Oncology Reports|December 23, 2022
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)Pasquale Lombardi, Giacomo Aimar, Caterina Peraldo-Neia, et al.Oncotarget|August 20, 2016
HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectivesValentina Fanotto, Elena Ongaro, Karim Rihawi, et al.International Journal of Cancer|September 3, 2020
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapyValentina Giannini, Samanta Rosati, Arianna Defeudis, et al.European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patientsStefano Cascinu, Gerardo Rosati, Guglielmo Nasti, et al.The Oncologist|September 8, 2012
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective studyMarco Tampellini, Azzurra Ottone, Elisa Bellini, et al.Plos One|January 21, 2018
Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFRCaterina Peraldo-Neia, Giuliana Cavalloni, Elisabetta Fenocchio, et al.Human Genomics|December 19, 2022
Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profilesLaila Akhouayri, Paola Ostano, Maurizia Mello-Grand, et al.Journal of Cardiothoracic Surgery|May 5, 2022
Prediction of preoperative intrathoracic adhesions for ipsilateral reoperations: sliding lung signGaetana Messina, Mary Bove, Antonio Noro, et al.Pageof 13